The University of Southampton
University of Southampton Institutional Repository

Reduced foetal growth and growth hormone secretion in adult life

Reduced foetal growth and growth hormone secretion in adult life
Reduced foetal growth and growth hormone secretion in adult life

OBJECTIVES: Recent studies suggest that growth restriction or other adverse influences acting in utero or during early infancy lead to permanent alterations in growth hormone (GH) secretion. As GH secretion is known to predict cardiovascular risk, alterations in GH may contribute to the association between reduced foetal growth and cardiovascular disease. We have therefore assessed the relationship between birth size and GH secretion in a prospective study of young adults whose birth size was recorded and who have had their current blood pressure and glucose tolerance measured. DESIGN Prospective cohort study PATIENTS: 153 healthy men and women, aged 20-21 years. MEASUREMENTS Subjects carried out a timed overnight urinary collection for analysis of GH excretion. Insulin sensitivity and insulin secretion were measured using the intravenous glucose tolerance test with minimal model analysis. Blood pressure, height, weight, usual level of exercise, smoking habits, alcohol consumption, and socio-economic status were also recorded. RESULTS: GH excretion ranged from 0.01 to 41.8 μU per subject. It did not differ according to gender but was markedly reduced in obese subjects (P<0.0001) Low birthweight was strongly associated with low GH excretion at age 20 years (P=0.002). Low placental weight and short body length also predicted low GH (P=0.02 and P=0.04, respectively). These relationships were independent of other confounding factors including obesity. GH excretion was not independently related to current levels of blood pressure, insulin sensitivity or insulin secretion. CONCLUSIONS: Body size at birth predicts GH excretion in adult life. Low GH excretion in people who were small at birth may be one mechanism explaining their increased risk of cardiovascular disease.

0300-0664
735-740
Flanagan, Daniel E.
954e7026-776b-4764-b6bb-3c98418c4a7c
Moore, Vivienne M.
d7664802-a369-4b96-9994-77f081d8b7eb
Godsland, Ian F.
14b7bc11-1919-40ce-a169-1f07b7b19b4e
Cockington, Richard A.
76907b95-2fe5-4526-a1db-35a2bf251392
Robinson, Jeffrey S.
7523d6ff-6eb2-489a-8479-01259887c1f3
Phillips I, David W.
29b73be7-2ff9-4fff-ae42-d59842df4cc6
Flanagan, Daniel E.
954e7026-776b-4764-b6bb-3c98418c4a7c
Moore, Vivienne M.
d7664802-a369-4b96-9994-77f081d8b7eb
Godsland, Ian F.
14b7bc11-1919-40ce-a169-1f07b7b19b4e
Cockington, Richard A.
76907b95-2fe5-4526-a1db-35a2bf251392
Robinson, Jeffrey S.
7523d6ff-6eb2-489a-8479-01259887c1f3
Phillips I, David W.
29b73be7-2ff9-4fff-ae42-d59842df4cc6

Flanagan, Daniel E., Moore, Vivienne M., Godsland, Ian F., Cockington, Richard A., Robinson, Jeffrey S. and Phillips I, David W. (1999) Reduced foetal growth and growth hormone secretion in adult life. Clinical Endocrinology, 50 (6), 735-740. (doi:10.1046/j.1365-2265.1999.00718.x).

Record type: Article

Abstract

OBJECTIVES: Recent studies suggest that growth restriction or other adverse influences acting in utero or during early infancy lead to permanent alterations in growth hormone (GH) secretion. As GH secretion is known to predict cardiovascular risk, alterations in GH may contribute to the association between reduced foetal growth and cardiovascular disease. We have therefore assessed the relationship between birth size and GH secretion in a prospective study of young adults whose birth size was recorded and who have had their current blood pressure and glucose tolerance measured. DESIGN Prospective cohort study PATIENTS: 153 healthy men and women, aged 20-21 years. MEASUREMENTS Subjects carried out a timed overnight urinary collection for analysis of GH excretion. Insulin sensitivity and insulin secretion were measured using the intravenous glucose tolerance test with minimal model analysis. Blood pressure, height, weight, usual level of exercise, smoking habits, alcohol consumption, and socio-economic status were also recorded. RESULTS: GH excretion ranged from 0.01 to 41.8 μU per subject. It did not differ according to gender but was markedly reduced in obese subjects (P<0.0001) Low birthweight was strongly associated with low GH excretion at age 20 years (P=0.002). Low placental weight and short body length also predicted low GH (P=0.02 and P=0.04, respectively). These relationships were independent of other confounding factors including obesity. GH excretion was not independently related to current levels of blood pressure, insulin sensitivity or insulin secretion. CONCLUSIONS: Body size at birth predicts GH excretion in adult life. Low GH excretion in people who were small at birth may be one mechanism explaining their increased risk of cardiovascular disease.

This record has no associated files available for download.

More information

Published date: 1999

Identifiers

Local EPrints ID: 476359
URI: http://eprints.soton.ac.uk/id/eprint/476359
ISSN: 0300-0664
PURE UUID: 9fe6ff0d-d501-4a82-887c-53d76baf7fc1

Catalogue record

Date deposited: 19 Apr 2023 16:46
Last modified: 17 Mar 2024 00:43

Export record

Altmetrics

Contributors

Author: Daniel E. Flanagan
Author: Vivienne M. Moore
Author: Ian F. Godsland
Author: Richard A. Cockington
Author: Jeffrey S. Robinson
Author: David W. Phillips I

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×